Lifeboat Foundation

Žilvinas DeveikaIt’s much sooner than that. My prediction (that is almost 10 years old now) of an “early” appearance of a strong AGI is 2029. I am completely sure that it will either emerge or will already be there in 2030s.

24 Replies.

Marc O MonfilsAnd what strategies do we have in place to guarantee humanity’s continued relevance in the era of super intelligent machines?

Continue reading “Chinese hacking group Aoqin Dragon quietly spied orgs for a decade” »

Elon Musk tells customers not to use Tesla’s recirculation mode because it spikes carbon dioxide levels in the car cabin.

Machines bristling with cameras and controlled by artificial intelligence are bringing supernatural precision to weeding, harvesting and fertilizing.

You may want to think twice before giving the parking attendant your Tesla-issued NFC card.

During my research, preparing my next presentations, i found this beautiful speech by Krafft Ehricke, in 1984, before he passed away.

Every single word is a precious teaching, a beautiful lecture on natural philosophy.

Continue reading “Krafft Ehricke: ‘Lunar Industrialization & Settlement—Birth of Polyglobal Civilization’” »

New artificial skin for bionic arm or AI robot | breakthrough photonic chip processes 2 billion images per second without memory device.

AI news includes new artificial skin to let AI robot, bionic arm or prosthetic limb feel with extreme touch sensitivity. New photonic chip allows AI to process and classify 2 billion images per second without needing storage device.

Continue reading “New Artificial Skin Lets Bionic Arm Or AI Robot Touch & Feel With Extreme Sensitivity” »

European Union policymakers have brought in new laws to introduce a universal phone charger.

Now it’s almost a reality, but while there’s widespread support from consumers and politicians, one company in particular isn’t happy.

Several years ago, a promising therapeutic using stem cell factor (SCF) emerged that could potentially treat a variety of ailments, such as ischemia, heart attack, stroke and radiation exposure. However, during clinical trials, numerous patients suffered severe allergic reactions and development of SCF-based therapeutics stopped.

A research team led by engineers at The University of Texas at Austin has developed a related therapeutic that they say avoids these major allergic reactions while maintaining its therapeutic activity. The keys to the discovery, published recently in Nature Communications, were the use of a similar, membrane-bound version of SCF delivered in engineered lipid nanocarriers.

“We envision this as something you can inject where you have lack of blood flow and it could induce blood vessels to grow in that area,” said Aaron Baker, a professor in the Cockrell School of Engineering’s Department of Biomedical Engineering, and one of the leaders on the project.